Hiroshi Nakamura
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 22, 2025
Relationship between the Montgomery-Åsberg Depression Rating Scale and Sheehan Disability Scale in patients with bipolar depressive episodes.Hidehiro Oshibuchi, Hiroshi Nakamura, Kazumasa Yoshida
|Feb 08, 2022
Efficacy and Safety of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study.Takuya Saito, Saori Sugimoto, Reiko Sakaguchi
|Oct 06, 2021
Long-Term Safety and Efficacy of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 52-Week, Multicenter, Open-Label Extension Study.Takuya Saito, Yohei Hyodo, Reiko Sakaguchi
|Sep 08, 2021
Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies.Mitsukuni Murasaki, Yoshifumi Inoue, Hiroshi Nakamura
|Dec 29, 2019
Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study.Nakao Iwata, Jun Ishigooka, Ichiro Naoi
|Dec 03, 2019
Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8-week, multicenter, double-blind, randomized controlled study.Philip D Harvey, Hiroshi Nakamura, Sadanori Miura
Pageof 1
